Susceptibility genes for AD identified in genome-wide association studies (GWAS) include APOE, complement receptor 1 (CR1), clusterin (CLU) and phosphatidylinositol binding clathrin assembly protein (PICALM; Lambert et al., 2009, 2011). This evidence concerns the gene CR1 and Alzheimer disease.